July 2, 2026
9:58 pm

Independent Life Expectancy Reports: Why Two Are Ordered

Two independent life expectancy reports are ordered in a life settlement because longevity estimation is inherently uncertain, and using opinions from two separate underwriting firms protects both buyer and seller from the errors and biases of any single methodology. Each report takes roughly 2-6 weeks and converts the insured’s medical records into a survival curve that drives the policy’s price. When the two reports disagree — which is common — buyers blend them or use the more conservative figure, and that choice directly shapes the offer. The two-report convention is one of the quiet structural safeguards that turned a once-chaotic market into an institutional asset class.

This article explains where the dual-report convention came from, how the firms differ, what happens when reports diverge, and the questions sellers should ask about how their reports were used.

In This Article

The Problem Two Reports Solve
What “Independent” Actually Means
How Two Firms Read the Same File Differently
Blending, Averaging, or Worst-Case: How Buyers Combine Reports
The 2008 Lesson: What Happens When Estimates Are Wrong at Scale
Cost, Timing, and Logistics of the Reports
What Sellers Should Ask About Their Reports
Frequently Asked Questions

Independent Life Expectancy Reports: Why Two Are Ordered

The Problem Two Reports Solve

Estimating how long a person will live is not a solved problem. It is a probabilistic judgment assembled from medical records, mortality tables, and experience data — and every step involves discretion. Which conditions matter most? How do multiple impairments interact? How current is the data? Different professional underwriters, all competent and honest, answer these questions differently.

A single life expectancy (LE) report therefore carries model risk: the possibility that one firm’s methodology is systematically off — too short, too long, or miscalibrated for a particular impairment class. For a buyer, relying on one report means betting a seven-figure purchase on one firm’s tables. For a seller, it means the offer could be depressed by one firm’s conservative read of an ambiguous chart.

Ordering two reports from independent firms is the market’s answer. The logic mirrors any high-stakes estimation problem:

Error dampening. Two uncorrelated estimates average out idiosyncratic mistakes better than one;
Outlier detection. A large gap between reports flags a case needing scrutiny — ambiguous records, a rapidly evolving condition, or a data gap;
Negotiating legitimacy. Both sides of the transaction can point to independent, professionally issued numbers rather than arguing from self-interest.

The convention hardened after the industry’s formative shock: the 2008 revisions in which major underwriting firms lengthened their estimates and single-source portfolios were badly impaired — an episode covered in the GAO’s 2010 report and in our history of life settlements. The market’s institutional buyers, described in who buys life insurance policies, now treat multi-report underwriting as baseline discipline.

What “Independent” Actually Means

Independence in this context has three distinct layers, and each one carries weight.

Independent of the transaction parties. The underwriting firm is not owned by, affiliated with, or compensated contingent on the interests of the buyer, the seller, the broker, or the provider. It is paid a flat fee for the report whether or not the settlement closes and regardless of the price. This severs the obvious conflict: an estimator who profits from the deal has an incentive to shade the number toward whichever answer closes it.

Independent of each other. The two reports come from different firms with separate proprietary methodologies, mortality tables, and clinical teams. Two reports from the same firm would be one opinion photocopied. Genuine methodological diversity is what makes the second report informative rather than redundant.

Independent of the issuing carrier. The insurance company that wrote the policy plays no role in settlement-stage underwriting. Its original issue-age underwriting is decades stale, and its interests (it prefers policies to lapse) are adverse to accurate secondary-market pricing.

Regulation reinforces the structure. Several states license or register life expectancy providers, impose accuracy and record-keeping duties, and prohibit fraudulent underwriting practices under statutes descending from the NAIC Life Settlements Model Act. Reputable firms also publish actual-to-expected (A/E) studies — retrospective audits comparing predicted mortality against what actually happened in their underwritten populations — which function as public accuracy report cards. A firm whose A/E ratio drifts loses institutional clients quickly, aligning long-run incentives with honest estimation. The full anatomy of the underlying analysis appears in life expectancy assessments in life settlements.

How Two Firms Read the Same File Differently

Sellers are often startled that two professional firms, given identical records, return estimates that differ by months or even years. The divergence is structural, not sloppy.

Base tables. Each firm maintains its own baseline mortality tables, calibrated to the older-age, insured, settlement-market population — itself a niche dataset — and updates them on its own schedule as longevity improves.
Debit-credit schedules. The mortality loadings assigned to specific conditions (heart failure severity classes, cancer stages, dementia progression) are proprietary and differ firm to firm.
Comorbidity modeling. Whether diabetes plus vascular disease multiplies, adds, or interacts nonlinearly is a modeling choice with real consequences at older ages.
Clinical judgment. Ambiguous charts — an untreated finding, a condition described inconsistently across physicians — get interpreted by humans with different priors.
Improvement assumptions. Firms differ on how much future mortality improvement (people living longer over time) to build into projections.

Divergence follows recognizable patterns: estimates agree most closely on clear-cut profiles (advanced age, well-documented major impairments) and diverge most on ambiguous middle cases — the 72-year-old with moderate, well-managed conditions. Unsurprisingly, those middle cases are also where offers vary most between buyers.

For the pricing model, the divergence is an input, not a nuisance: the spread between reports is itself information about uncertainty, and wider spreads generally push buyers toward conservative pricing. How that conservatism flows into the bid is the subject of life settlement pricing mechanics.

Report Combination Method	How It Works	Effect on Offer	When Buyers Use It
Straight average	Mean of the two median LEs (or blended survival curves)	Neutral — balances both opinions	Default for cases where reports are reasonably close
Weighted blend	More weight to the firm with the stronger actual-to-expected record or relevant specialty	Depends on which report is favored	Buyers with strong views on firm accuracy by impairment class
Longer-of-two (conservative)	Price off the longer estimate only	Systematically lower offers	Cautious funds; ambiguous or fast-changing medical profiles
Median of three	Order a third report when the first two diverge widely; use the middle value	Moderates the effect of an outlier report	Divergence of roughly 24+ months; large face values
Re-underwrite	Refresh reports after material health change or ~12 months of staleness	Can raise or lower prior indications	Stalled transactions; portfolio revaluations

How Two Firms Read the Same File Differently

Blending, Averaging, or Worst-Case: How Buyers Combine Reports

Once two reports arrive, the buyer must reduce them to a single survival curve for the discounted cash flow model. The combination rule is a genuine pricing decision — and one sellers rarely know to ask about.

Common approaches:

Straight average. The median LEs (or full curves) are averaged. Balanced, and the most common baseline.
Weighted blend. The buyer weights the firm whose A/E track record it trusts more, or whose specialty matches the dominant impairment.
Longer-of-two (conservative). The buyer prices off the longer estimate, assuming more premium years and a later death benefit. This systematically lowers offers and is common among cautious funds or in uncertain cases.
Third-report tiebreaker. When the two reports diverge widely — say by 24 months or more — many buyers order a third report and use the median of three.

The seller-side implication is direct: two buyers holding identical reports can bid differently purely because of their combination rule. A fund averaging 78 and 102 months prices off 90; a fund using longer-of-two prices off 102 — and its bid will be meaningfully lower on the same facts. This is one of several reasons competitive shopping matters, as argued in how life settlement value is calculated: an auction across buyers with different combination rules gives the seller the benefit of the most favorable defensible interpretation.

Honest disclosure: none of these rules is “correct.” Longevity uncertainty is real, and conservative blending reflects genuine risk that buyers bear — the same risk explored from the investor’s chair in how life settlement investors make money.

The 2008 Lesson: What Happens When Estimates Are Wrong at Scale

The two-report convention is best understood through the event that entrenched it. Through the mid-2000s, capital poured into life settlements, and many portfolios were priced using estimates from a small number of underwriting firms whose methodologies, it turned out, ran short — insureds were living longer than the tables predicted.

In 2008, major LE firms revised their methodologies, lengthening estimates substantially in one step. The consequences rippled through the market:

Portfolio markdowns. Policies priced on the old, shorter estimates were suddenly worth less: more premium years ahead, death benefits further out. Funds holding them recorded losses; some collapsed.
Litigation. Investors sued over valuation practices; disputes over reliance on single-source estimates ran for years.
Regulatory attention. The episode fed into the GAO’s examination of the market and reinforced state-level scrutiny of underwriting practices within the NAIC framework.

The structural reforms that followed define current practice: multiple independent reports per policy; systematic tracking of each firm’s actual-to-expected accuracy; conservative blending rules; periodic re-underwriting of held portfolios; and stress-testing of returns against further methodology lengthening.

For sellers, the history cuts both ways. It explains why buyers are conservative — they have been burned by optimism before — and it validates the system’s self-correction: the market now prices longevity uncertainty explicitly instead of ignoring it. The broader arc from viatical-era improvisation to institutional discipline is traced in the history of life settlements.

Cost, Timing, and Logistics of the Reports

Practical mechanics matter to a seller planning around the 60-120 day transaction window.

Who orders and pays. In the standard flow, the broker or provider orders the reports once the medical file is assembled, and the cost is borne by the buy side or the intermediary as a transaction expense — reports each cost several hundred dollars or more depending on rush status and case complexity. Sellers should confirm in writing whether any report costs will be netted from proceeds; practices vary and disclosure rules require clarity about all deductions.

Timing. Each report takes roughly 2-6 weeks from receipt of a complete file. Ordered in parallel, the two reports overlap rather than stack. The gating item is almost always the medical records themselves: underwriting firms cannot start on an incomplete chart, and physician offices are the slowest link in the chain. Sellers who deliver a complete provider list and prompt authorizations effectively buy back weeks, as detailed in how life settlements work.

Shelf life. Reports are treated as current for roughly twelve months, less if health changes materially. A stalled transaction may require refreshed reports — new cost, new weeks.

Format. Each report states a median LE in months, a mortality multiplier, and the underlying survival curve. Sellers and their advisors can request to see the reports or at least the medians used; transparency practices vary by intermediary, and willingness to share is a useful integrity signal when choosing between the routes described in life settlement broker vs. provider.

What Sellers Should Ask About Their Reports

Because the reports substantially determine the offer, a seller’s due diligence should treat them as first-class documents. Six questions cover the ground:

“Which firms underwrote my case?” Established firms with published actual-to-expected studies carry more weight; an unfamiliar or affiliated estimator is a flag.
“What were the two median estimates?” You are entitled to know the numbers driving your price. Large divergence between them explains conservative bids and may justify a third report.
“How were the reports combined in the winning bid?” Average, weighted, or longer-of-two — the rule can move the offer materially.
“Was my file complete when underwritten?” Missing specialist records mean uncredited impairments and a longer estimate than the facts support. If gaps are found, ask whether refreshed underwriting is worthwhile.
“How many buyers priced off these reports?” The same reports shown to eight funds produce a market; shown to one, a take-it-or-leave-it number.
“Will any underwriting costs be deducted from my proceeds?” Get every deduction in writing before signing.

Two framing reminders keep the exercise grounded. First, the reports price the policy, not the person: the legal right to sell descends from Grigsby v. Russell, and the estimate is an actuarial statement about populations, never a prognosis. Second, the number that ultimately matters is net-after-tax proceeds compared against alternatives — surrender value, retention, or reduced coverage — a comparison that runs through the IRS three-tier rules of Rev. Rul. 2009-13 summarized in the tax treatment guide and the framework in life settlement vs. surrender.

Frequently Asked Questions

Why do life settlement buyers order two life expectancy reports instead of one?

Because longevity estimation carries model risk: any single firm’s tables and judgment can run systematically short or long. Two reports from independent firms with different methodologies dampen individual errors, flag ambiguous cases when they diverge, and give both sides numbers that neither party controls. The convention hardened after 2008, when major underwriting firms lengthened their methodologies and portfolios priced on single-source estimates were significantly impaired. Today, dual independent reports are baseline institutional discipline, and some buyers order a third when the first two disagree widely.

What makes a life expectancy report independent?

Three things. The underwriting firm is unaffiliated with the buyer, seller, broker, and provider, and is paid a flat fee regardless of whether the deal closes or at what price. The two reports come from different firms with separate proprietary methodologies, so the second opinion adds genuine information. And the issuing insurance carrier plays no role. Several states license or register life expectancy providers under frameworks descending from the NAIC Life Settlements Model Act, and reputable firms publish actual-to-expected accuracy studies that function as public report cards.

What happens if my two life expectancy reports are very different?

Meaningful divergence is common and structural — firms use different mortality tables, condition loadings, and clinical judgment. Buyers respond by averaging the estimates, weighting the firm they trust more, pricing off the longer figure, or ordering a third report and using the median. Wide divergence usually signals an ambiguous medical file and tends to push pricing conservative. As a seller, you are entitled to ask what the two medians were and how they were combined in your bid, since a longer-of-two rule produces a visibly lower offer than an average.

How long do independent life expectancy reports take and how long are they valid?

Each report takes roughly 2-6 weeks once the underwriting firm has a complete medical file, and the two are typically ordered in parallel so they overlap. The slower step is usually assembling records from physician offices beforehand. Reports are generally treated as current for about twelve months, less if the insured’s health changes materially. A transaction that stalls past the shelf life may require refreshed underwriting — additional cost and additional weeks — which is one reason to move promptly once the process starts.

Who pays for the life expectancy reports in a life settlement?

In the standard market flow, the buy side or the intermediary bears the cost of the reports as a transaction expense; each report costs several hundred dollars or more depending on complexity and rush status. Practices vary, however, and some arrangements net underwriting costs against the seller’s proceeds. State disclosure rules require deductions to be spelled out, so sellers should ask directly, in writing, whether any report or underwriting costs will reduce their net payment — and get the full list of deductions before signing the settlement contract.

Can I see the life expectancy reports used to price my policy?

Often yes, and asking is worthwhile. Transparency practices vary by broker and provider, but many will share the reports or at least the median estimates and the names of the underwriting firms. A cooperative intermediary should also explain how the two estimates were combined in the winning bid. Willingness to share is a useful integrity signal; reluctance to disclose even the medians that determined your price is a reason to slow down and consider whether the process has been genuinely competitive.

Did life expectancy underwriting really cause fund losses in the past?

Yes. Through the mid-2000s, many portfolios were priced on estimates that proved too short — insureds lived longer than the tables predicted. In 2008, leading underwriting firms lengthened their methodologies substantially, and policies bought under the old assumptions were marked down: more premium years remained and death benefits sat further out. Some funds failed, litigation followed, and the GAO’s 2010 market study documented the fallout. The reforms that emerged — dual reports, accuracy tracking, conservative blending — define today’s underwriting discipline.

Does a longer life expectancy estimate mean I can’t sell my policy?

Not necessarily, but it lowers the price and can push marginal policies below buyers’ thresholds. A longer estimate means more premium years for the buyer to fund and a more heavily discounted death benefit, so the modeled value falls — sometimes to a level where no institutional bid appears, particularly for younger or healthier insureds with expensive premiums. Policies with low or guaranteed premiums remain marketable at longer estimates because carrying costs are manageable. A qualification review before full underwriting can spare sellers a pointless process.

Find out what your policy is worth — free, confidential, no obligation.

A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.

Call (305) 209-7183 · Request a review online →

Table of Contents